B of A Securities Upgrades Sabra Health Care REIT to Neutral, Raises Price Target to $14
Portfolio Pulse from richadhand@benzinga.com
B of A Securities analyst Joshua Dennerlein has upgraded Sabra Health Care REIT (NASDAQ:SBRA) from Underperform to Neutral and raised the price target from $11 to $14.
August 11, 2023 | 1:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Sabra Health Care REIT has been upgraded to Neutral from Underperform by B of A Securities, with a price target increase from $11 to $14.
The upgrade from Underperform to Neutral indicates a more positive outlook on the company by the analyst. The increase in price target from $11 to $14 suggests that the analyst believes the stock has potential for growth. This could lead to increased investor interest and potentially a rise in stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100